Dr Krishna Prasad Chigurupati has submitted a revised disclosure concerning the sale of 1,72,00,000 equity shares in Granules India Limited. The transaction, which took place on September 11, 2026, represents a substantial change in the promoter’s holding. This disclosure also details the holdings of persons acting in concert with the promoter, reflecting the adjusted ownership structure post-sale.
Revised Shareholding Disclosure Filed for Granules India
Dr Krishna Prasad Chigurupati has filed a revised disclosure document, as per Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure pertains to the sale of 1,72,00,000 equity shares of Granules India Limited, which was executed on September 11, 2026. This filing is a continuation of a prior disclosure made on the same date.
Details of the Transaction
The revised disclosure provides an updated view of the shareholding patterns following the sale. It confirms that Dr. Chigurupati’s individual holding and the collective holdings of persons acting in concert have been impacted by this transaction. The document reiterates that the number of shares sold and Dr. Chigurupati’s own shareholding, both before and after the sale, remain as stated in the original disclosure.
Shareholding Before and After
Prior to the sale, the collective holding of the promoter and persons acting in concert was 9,42,03,525 shares, representing 38.02% of the total share capital. Following the sale of 1,72,00,000 shares, their total holding is now 7,70,03,525 shares, equating to 31.08% of the total share capital. Dr. Krishna Prasad Chigurupati’s direct holding before the sale was 7,68,08,111 shares, which reduced to 5,96,08,111 shares post-sale.
Impact on Diluted Shareholding
The disclosure also highlights the impact on diluted shareholding. Before the transaction, the diluted share capital stood at 27,27,96,921 equity shares. After the sale, the diluted share capital remains at 27,27,96,921 equity shares, reflecting the potential conversion of outstanding warrants and convertible securities.
Source: BSE
